The Circulating Fibrocyte - a Novel and Accurate Biomarker in Diagnosing Acute Appendicitis in Adults
NCT ID: NCT03988660
Last Updated: 2019-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
95 participants
OBSERVATIONAL
2015-06-10
2019-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
95 consecutive adults were recruited in a cohort based prospective study at University Hospital Limerick, 15 were healthy individuals and 80 were patients with RIFP. Peripheral venous samples were obtained at presentation. Clinical, biochemical and histo-pathological parameters were recorded. CF levels were determined by dual-staining for CD45 and Col-1 using FACS and correlated with histopathological diagnoses. P\<0.05 was taken as significant.
The study hypothesis is that in patients with suspected appendicitis, CF levels may improve the diagnostics, reduce unnecessary radiation and negative appendicectomy rates.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Performance of C Reactive Protein and Delta CRP in Acute Appendicitis
NCT02730585
Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation
NCT00528138
Diagnostic Value of Hyperbilirubinaemia as a Predictive Factor for Appendiceal Perforation in Acute Appendicitis
NCT00677417
Inflammatory Response in Appendicitis
NCT01718171
Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation
NCT06956638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Circulating fibrocytes (CFs) were first described in 1994 by Richard Bucala. They are haematopoietic cells derived from the bone marrow. They circulate in the monocyte fraction and can differentiate into myelofibrocytes, fibroblasts and adipocytes (among other cell types). They have a prominent role in inflammatory and healing processes, and in the development of fibrosis.
No studies to date have examined the role of CFs in acute appendicitis. Thus, the aims of this clinical trial were (1) to determine if CFs are altered in acute appendicitis, (2) to assess and compare their diagnostic accuracy with CRP, WCC, neutrophils, lymphocytes, neutrophils-lymphocytes ratio (NLR), monocytes, basophils and eosinophils, and (3) to determine the most reliable predictors in diagnosing AA.
A prospective cohort study was undertaken to (1) determine circulating fibrocytes levels (CF) in patients with histologically confirmed acute appendicitis (AA), and (2) to determine the sensitivity and specificity of circulating CF levels in the diagnosis of AA, in adults (age ≥ 16 years) presenting acutely with right iliac fossa pain, at the University hospital Limerick. The diagnosis of appendicitis was confirmed by histopathological assessment following appendicectomy.
Patients were divided in three cohorts following their final diagnosis on discharge and based on the histopathology results. (1) patients with RIFP who underwent an appendicectomy and had a normal appendix at histological assessment i.e histologically proven normal appendix group (HPNG). (2) patients with RIFP who underwent an appendicectomy and had an inflamed appendix at histological assessment i.e histologically proven appendicitis group (HPAG). (3) patients with RIFP who had an alternate diagnosis on discharge other than appendicitis i.e alternative diagnosis group (ADG). Another cohort was added as (4) healthy controls.
Data collected included date of admission, patient's gender, age, presenting symptoms, duration of symptoms, CF levels, preoperative WCC and its differentials (neutrophil, lymphocyte, neutrophils-lymphocytes ratio (NLR), monocyte, basophil and eosinophil counts), CRP, final clinical diagnosis, operation and post-operative diagnosis based at histological assessment.
Peripheral venous samples were obtained from patients in cohort 1, 2 and 3 (n= 80) and healthy controls (n=15). A single 10 mL sample of heparinized venous blood was collected via peripheral, upper extremity venipuncture. Samples were collected in sodium heparin (EDTA) vacutainer tubes and transferred to the laboratory within 3 hours. Samples were then processed to isolate the buffy coat layer using density gradient centrifugation (Histopaque, Sigma-Aldrich, Wicklow, Ireland). The resulting peripheral blood mononuclear cells were subsequently washed in Phosphate-buffered saline (PBS) and re-suspended in freezing medium (50% foetal bovine serum, 40% RPMI medium and 10% dimethyl sulfoxide) prior to transfer to cryogenic vials in 1-ml aliquots. Finally, samples were cooled in a cryogenic temperature control rate container to -80 °C until processing for flow cytometry. Following white blood cell isolation using density gradient centrifugation, 1×106cells were re-suspended in flow cytometry buffer (RPMI medium supplemented with 10% horse serum, 0.1% sodium azide and 25 mM HEPES). Cells were fixed and permeabilised using BD Cytofix/Cytoperm solution (BD Biosciences, Oxford, England) and blocked prior to intracellular staining of Collagen-I with mouse anti-human Collagen-I antibody (Millipore, Cork, Ireland, Product code MAB3391) which was subsequently stained with Alexa-Fluor 488 goat anti-mouse secondary antibody (Jackson ImmunoResearch Europe, Suffolk, England; Product code 115-545-146). Cells were then stained for cell surface antigen CD45 using PerCP anti-human CD45 (Biolegend, London, England). Cells were then re-suspended in PBS before subsequent analysis on the flow cytometer (BD FACSVerse). All analysis was done on a BD FACSVerse (BD Biosciences) using BD FACSuite v1.0.5 (BD Biosciences). Fibrocyte levels were displayed as a percentage of the total white blood cell population.
Data analyses were performed using IBM SPSS for Mac OSX version 25.0. Data were presented as means and standard deviations, or medians and interquartile ranges, as appropriate. Distribution of variables was assessed by histograms, Q-Q plots, and box plots. Analysis of Variance (One-Way ANOVA) was used to compare between different independent groups. Kruskal-Wallis test was used to compare between the biomarkers and the different groups (HPNG vs. HPAG vs. ADG), and for subgroup analysis pairwise comparisons were performed, a P - value of less than 0.05 was considered statistically significant. Receiver operating characteristic (ROC) curve was used to characterize and compare between the diagnostic accuracy of CFs, WCC, CRP, neutrophils, NLR and monocytes. Multinomial logistic regression analysis was used to assess for independent predictors for AA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls
Healthy individuals
Circulating fibrocytes
Peripheral blood samples were taken from the patients presented with right iliac fossa pain. Samples were collected in sodium heparin (EDTA). Circulating fibrocyte levels were determined by dual staining peripheral blood samples for CD4 and Col-1 using Fluorescence-Activated Cell Sorting (FACS) and correlated with histopathological diagnosis.
Histologically confirmed appendicitis
Patients who have diagnosis of appendicitis on histology
Circulating fibrocytes
Peripheral blood samples were taken from the patients presented with right iliac fossa pain. Samples were collected in sodium heparin (EDTA). Circulating fibrocyte levels were determined by dual staining peripheral blood samples for CD4 and Col-1 using Fluorescence-Activated Cell Sorting (FACS) and correlated with histopathological diagnosis.
Histologically normal appendix
Patients who have diagnosis of a normal appendix on histology
Circulating fibrocytes
Peripheral blood samples were taken from the patients presented with right iliac fossa pain. Samples were collected in sodium heparin (EDTA). Circulating fibrocyte levels were determined by dual staining peripheral blood samples for CD4 and Col-1 using Fluorescence-Activated Cell Sorting (FACS) and correlated with histopathological diagnosis.
Alternative diagnosis group
Patients who diagnosed with a condition other than appendicitis
Circulating fibrocytes
Peripheral blood samples were taken from the patients presented with right iliac fossa pain. Samples were collected in sodium heparin (EDTA). Circulating fibrocyte levels were determined by dual staining peripheral blood samples for CD4 and Col-1 using Fluorescence-Activated Cell Sorting (FACS) and correlated with histopathological diagnosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Circulating fibrocytes
Peripheral blood samples were taken from the patients presented with right iliac fossa pain. Samples were collected in sodium heparin (EDTA). Circulating fibrocyte levels were determined by dual staining peripheral blood samples for CD4 and Col-1 using Fluorescence-Activated Cell Sorting (FACS) and correlated with histopathological diagnosis.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 16 years old or more
Exclusion Criteria
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Limerick
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Zarog
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Limerick
Limerick, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zarog M, O'Leary P, Kiernan M, Bolger J, Tibbitts P, Coffey S, Byrnes G, Peirce C, Dunne C, Coffey C. Circulating fibrocyte percentage and neutrophil-lymphocyte ratio are accurate biomarkers of uncomplicated and complicated appendicitis: a prospective cohort study. Int J Surg. 2023 Mar 1;109(3):343-351. doi: 10.1097/JS9.0000000000000234.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
University of Limerick
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.